Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | 27G79 | IM / LA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | D2D49 | IM / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Z016247 | SC / RA |
rash location is face and both arms. The describes the rash as itchy and papular. Associated symptoms include pruritus. pertinent negatives include abdominal pain, chills, cough, diarrhea, dyspagia, dyspnea, fever, headache, joint swelling, lethargy, lymphadenopathy, nausea, pharyngitis, vomiting, and wheezing.
Loratadine 5 mg/ 5 mL oral solution, hydrocortisone 1 % topical ointment, AmLactin 12 % lotion, acetaminophen 160 mg/ 5 mL oral liquid
NKDA